Ingestible sensors market was valued at $987.3 million in 2024 and is projected to reach $2,174.8 million by 2035, growing at a CAGR of 8.3% during the forecast period (2026-2035).The ingestible sensors market is gaining momentum due to rising demand for non-invasive diagnostics, real-time patient monitoring, improved medication adherence, and the growing shift toward personalized and remote healthcare. Among these drivers, artificial intelligence (AI) integration stands out as the strongest growth catalyst, as it transforms ingestible sensors from passive data-collecting devices into intelligent systems capable of real-time analysis, predictive insights, and clinically actionable decision support.

Pigmented villonodular synovitis drug market was valued at $42.8 million in 2025 and is projected to reach $53.2 million by 2035, growing at a CAGR of 2.2% during the forecast period (2026-2035). The limited feasibility of surgery and the growing need for effective systemic therapies is a major driver shaping the pigmented villonodular synovitis (PVNS) drug market, particularly within the diffuse and recurrent disease population. PVNS, also classified under tenosynovial giant cell tumors (TGCTs), is a rare however locally aggressive condition that primarily affects large joints and leads to progressive pain, swelling, and functional impairment.

Global personal care appliances market was valued at $23.4 billion in 2024 and is projected to reach $42.7 billion by 2035, growing at a CAGR of 5.7% during the forecast period (2025-2035). The global personal care appliances market is experiencing robust growth as consumer demand for convenient, high-performance grooming and wellness devices increases. Rising awareness of personal hygiene and appearance, coupled with evolving lifestyle preferences, is encouraging the adoption of advanced appliances such as hair stylers, shavers, oral care devices, and skincare tools.

Global omega-3 polyunsaturated fatty acids market was valued at $2.0 billion in 2025 and is growing at a CAGR of 6.0% during the forecast period (2026-2035). Dietary supplements play a significant role in providing omega-3 polyunsaturated fatty acids, especially for individuals with limited intake of fatty fish or plant-based omega-3 sources. These supplements commonly contain eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), or alpha-linolenic acid (ALA), which support normal physiological functions such as cardiovascular health, brain function, and inflammatory regulation. 

global myotonic dystrophy drug market was valued at $110.3 million in 2025 and is projected to reach $220.96 million by 2035, growing at a CAGR of 7.2% during the forecast period (2026-2035). Improved disease recognition and genetic confirmation a major driver supporting the expansion of the myotonic dystrophy drug market. It increases the identifiable and treatable patient pool across neurology, cardiology, and respiratory care settings. Public health sources indicate that myotonic dystrophy affects about 10 in 100,000 people of all ages, indicating a meaningful prevalence base for long-term pharmacologic management. 

Foundry tools market was valued at $5,311.5 million in 2025 and is projected to reach $10,397.3 million by 2035, growing at a CAGR of 6.5% during the forecast period (2026-2035). The foundry tools market is expanding due to increasing semiconductor complexity, rising demand for automotive and industrial electronics, and continued investments in advanced manufacturing technologies. As per IEA report, China is expected to maintain its leadership in electric vehicle (EV) sales through 2030, with around 80% market share, supported by competitive pricing and strong market momentum. Europe’s EV adoption is projected to reach close to 60%, while the United States sees a more modest increase to around 20% by 2030. In Southeast Asia, EV adoption is accelerating, with 1 in 4 cars and nearly 1 in 3 two- or three-wheelers expected to be electric by 2030.

Global Internet of Things (IoT) market was valued at $59.5 billion in 2024 and is growing at a CAGR of 24.5% during the forecast period (2025-2035). Enhanced 5G networks improve latency, reliability, and bandwidth, essential for real-time IoT applications, thus fostering market growth in smart manufacturing, autonomous systems, and connected healthcare. As per the 5G Americans Org., in April 2025,

global impetigo drug market was valued at $247.3 million in 2025 and is projected to reach $477.3 million by 2035, growing at a CAGR of 6.9% during the forecast period (2026-2035). The persistently high incidence of community-acquired bacterial skin infections, particularly among children, remains a primary driver underpinning growth of the market. Impetigo is one of the most frequently diagnosed pediatric skin infections and is highly contagious, prompting early clinical intervention and routine antibiotic prescribing.

Heavy-duty construction equipment market was valued at $211.2 billion in 2024 and is projected to reach $361.6 billion by 2035, growing at a CAGR of 5.1% during the forecast period (2026-2035). The global heavy-duty construction equipment market is experiencing sustained growth, driven by increasing investments in large-scale infrastructure, mining, and industrial development projects. Governments and private sector players are prioritizing transportation networks, energy facilities, and urban development, which is reinforcing demand for high-capacity earthmoving and material handling equipment. 

global Glycosylated hemoglobin and C-peptide market was valued at $2,945.0 million in 2025 and is projected to reach $6,240.2 million by 2035, growing at a CAGR of 7.9% during the forecast period (2026-2035. The growing global diabetes burden continues to expand the population requiring routine glycemic assessment and long-term metabolic monitoring, directly supporting demand for HbA1c and C-peptide testing. According to the International Diabetes Federation (IDF) Diabetes 11.1% of the global adult population, or 1 in 9 adults aged 20–79, is currently living with diabetes, with more than 40% remaining undiagnosed. In absolute terms, around 589 million adults were living with diabetes globally in 2024, indicating the scale of unmet diagnostic and monitoring needs across healthcare systems.